Cancer Drugs Fund

UK drug-pricing watchdog recommends Novartis CAR-T for leukemia in final draft guidance

NICE recommends Kymriah to the Cancer Drugs Fund due to remaining questions about evidence to support it, but believes those questions will be resolved.

By Alaric DeArment

Tackling Rising Drug Costs and Growing Popularity of GLP-1’s

See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.

By Quantum Health and MedCity News

Consultants: Help Define What’s Next In Healthcare Benefits

Help shape the future of healthcare benefits by sharing your insights.

By MedCity News

Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options

FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.

By FASENRA, Sponsored Content